Vitamin D3 and K2 are fat-soluble vitamins. Unlike water-soluble vitamins that are absorbed quickly, used immediately, and excreted within hours, fat-soluble vitamins accumulate gradually in body tissues and require consistent daily intake over weeks and months to build and maintain optimal levels. This fundamental pharmacokinetic reality has a direct implication for how you supplement: consistency over time matters more than any single dose.
This guide explains why long-term daily use is essential for D3 and K2 to deliver their full benefits, how the coconut oil softgel format optimizes absorption, what the clinical evidence says about the timeline for measurable outcomes, and why choosing the right supply size is a practical decision that directly affects supplementation consistency.
Table of Contents
- Fat-Soluble Vitamins: Why Consistency Is Everything
- How Long Does It Take to Raise Vitamin D Levels?
- MK-7: The K2 Form Designed for Once-Daily Dosing
- Why Coconut Oil Softgels Optimize Fat-Soluble Vitamin Absorption
- Bone Health: What the Clinical Evidence Says About Duration
- Cardiovascular Protection: The Long-Term MGP Activation Story
- Immune Function: Seasonal Consistency and Year-Round Protection
- Vitamin D in Canada: Why Year-Round Supplementation Matters
- Choosing the Right Supply Size: The Case for 300 Softgels
- What Is in Each Softgel
- 300 Softgels vs 120 Softgels: Full Comparison
- Dosage Guidelines and Timing
- Safety Profile and Contraindications
- Frequently Asked Questions
Fat-Soluble Vitamins: Why Consistency Is Everything
Vitamins are classified as either water-soluble (B vitamins, vitamin C) or fat-soluble (vitamins A, D, E, K). This distinction has profound implications for how they are absorbed, stored, and how supplementation should be approached.
Water-soluble vitamins dissolve in water, are absorbed directly into the bloodstream, and excess amounts are excreted in urine within hours. They require frequent replenishment but provide relatively rapid effects.
Fat-soluble vitamins dissolve in fat, are absorbed through the lymphatic system alongside dietary fats, and are stored in body fat and the liver. They accumulate gradually with consistent intake and are depleted slowly when intake stops. This storage capacity is both an advantage (a missed dose has minimal impact) and a requirement (building adequate tissue levels takes weeks to months of consistent supplementation).
The Tissue Level Building Curve
When you begin supplementing with vitamin D3, serum 25(OH)D levels (the storage form measured in blood tests) do not reach their new steady state immediately. Research published in the American Journal of Clinical Nutrition (2008) demonstrated that serum 25(OH)D levels rise gradually with consistent supplementation, typically reaching a new plateau after 2 to 3 months of daily intake. Similarly, vitamin K2 MK-7 accumulates in tissues over weeks of consistent daily dosing before reaching steady-state concentrations.
This means that the benefits of D3 and K2 supplementation are not fully realized in the first days or weeks. The clinical outcomes documented in research trials (improved bone mineral density, reduced arterial stiffness, enhanced immune function) are the result of sustained tissue-level adequacy over months, not acute supplementation.
How Long Does It Take to Raise Vitamin D Levels?
The timeline for raising serum 25(OH)D to optimal levels depends on baseline status, dose, body weight, and individual variation in vitamin D metabolism. General evidence-based timelines:
| Starting 25(OH)D Level | Target Level | Approximate Time at 1,000 IU Daily |
|---|---|---|
| Severely deficient (below 25 nmol/L) | 75 nmol/L (optimal) | 4 to 6 months |
| Deficient (25 to 50 nmol/L) | 75 nmol/L | 2 to 4 months |
| Insufficient (50 to 75 nmol/L) | 75 to 125 nmol/L | 1 to 3 months |
| Optimal (75 to 125 nmol/L) | Maintain | Ongoing daily supplementation |
Once optimal levels are achieved, daily supplementation must continue to maintain them. Serum 25(OH)D levels decline when supplementation stops, returning toward baseline over 2 to 3 months. This is why uninterrupted daily supplementation, supported by an adequate supply, is essential for sustained benefit.
Health Canada recommends testing serum 25(OH)D levels before and after supplementation to confirm adequacy. The optimal range is generally considered to be 75 to 125 nmol/L.
MK-7: The K2 Form Designed for Once-Daily Dosing
The choice of MK-7 (menaquinone-7) as the vitamin K2 form in this formula is directly relevant to the long-term daily use strategy. MK-7's pharmacokinetic profile makes it uniquely suited to once-daily supplementation.
MK-7 has a plasma half-life of approximately 72 hours (3 days), compared to 1 to 2 hours for MK-4 (the other common K2 form). This means:
- A single daily dose of MK-7 maintains stable, sustained blood and tissue levels throughout the 24-hour period between doses
- MK-7 accumulates in tissues over the first 2 to 4 weeks of daily supplementation, reaching steady-state concentrations that provide continuous activation of osteocalcin and Matrix Gla Protein (MGP)
- The long half-life provides a buffer against occasional missed doses without significant loss of tissue-level K2 activity
Research published in Thrombosis and Haemostasis (2015) confirmed that MK-7 supplementation at 180 mcg daily produced stable, sustained plasma K2 levels throughout the dosing interval, with no significant troughs between doses. This sustained activity is essential for the continuous osteocalcin carboxylation and MGP activation that underpin K2's bone and cardiovascular benefits.
The 120 mcg MK-7 dose per softgel is consistent with the doses used in clinical trials demonstrating significant improvements in bone mineral density and arterial stiffness.
Why Coconut Oil Softgels Optimize Fat-Soluble Vitamin Absorption
Both vitamin D3 and vitamin K2 are fat-soluble. Their absorption from the gastrointestinal tract requires the presence of dietary fat to stimulate bile secretion, form mixed micelles, and facilitate lymphatic uptake. Taking fat-soluble vitamins without fat significantly reduces their absorption.
The Coconut Oil Advantage
This formula uses organic non-GMO coconut oil as the carrier within each softgel. This is a deliberate formulation choice with meaningful absorption implications:
- Built-in fat carrier: The coconut oil within the softgel provides the dietary fat needed to initiate bile secretion and micelle formation for fat-soluble vitamin absorption, even when taken with a light meal or on an empty stomach
- Medium-chain triglycerides (MCTs): Coconut oil is rich in medium-chain triglycerides (MCTs), which are absorbed more rapidly than long-chain triglycerides and may enhance the absorption kinetics of co-administered fat-soluble compounds
- Consistent absorption: Unlike capsules or tablets that rely entirely on the fat content of the meal consumed alongside them, the coconut oil softgel provides a consistent fat matrix regardless of meal composition
Research published in the American Journal of Clinical Nutrition (2015) demonstrated that vitamin D3 absorption was significantly higher when taken with a fat-containing meal compared to a fat-free meal, with the fat content of the meal being the primary determinant of absorption efficiency. The coconut oil in this softgel addresses this variable directly.
Bone Health: What the Clinical Evidence Says About Duration
The most compelling clinical evidence for the D3 and K2 combination comes from long-term trials, and the duration of supplementation is directly correlated with the magnitude of benefit.
The 3-Year MK-7 Bone Trial
The landmark randomized controlled trial on MK-7 and bone health, published in Osteoporosis International (2013) by Knapen et al., involved 244 postmenopausal women supplemented with 180 mcg MK-7 daily for 3 years. Key findings:
- Significant improvements in bone mineral density (BMD) at the lumbar spine and femoral neck compared to placebo
- Significant improvements in bone strength indices (stiffness index, ultimate strength)
- Significant reduction in the rate of age-related bone loss
- Effects were progressive, with greater improvements observed at 2 and 3 years compared to 1 year
The progressive nature of the bone benefits is critical: the greatest improvements were seen at the longest duration of supplementation. This is consistent with the biology of bone remodeling, which occurs over cycles of 3 to 6 months, meaning that meaningful changes in bone mineral density require sustained supplementation over multiple remodeling cycles.
Osteocalcin Carboxylation Timeline
Research published in the British Journal of Nutrition (2012) demonstrated that MK-7 supplementation significantly increased the percentage of carboxylated osteocalcin (the active, calcium-binding form) within 4 weeks of daily supplementation, with maximum carboxylation achieved at 8 to 12 weeks. Maintaining this carboxylation state requires uninterrupted daily K2 intake.
Cardiovascular Protection: The Long-Term MGP Activation Story
Matrix Gla Protein (MGP), the most potent known inhibitor of arterial calcification, requires continuous vitamin K2 for activation. The cardiovascular protection provided by K2 is therefore inherently a long-term, continuous process.
The Arterial Stiffness Trial
The randomized controlled trial published in Thrombosis and Haemostasis (2015) by Knapen et al. involving 244 healthy postmenopausal women found that MK-7 supplementation (180 mcg daily) for 3 years produced:
- Significant reduction in pulse wave velocity (a measure of arterial stiffness) compared to placebo
- Significant improvement in arterial elasticity
- Effects were most pronounced in women with the highest baseline arterial stiffness
- The reduction in arterial stiffness was progressive over the 3-year period, with greater improvements at later time points
The progressive nature of the arterial stiffness reduction reflects the gradual reversal of existing arterial calcification through sustained MGP activation. This is a process that unfolds over years, not weeks, making long-term uninterrupted supplementation essential for cardiovascular benefit.
The Rotterdam Study Context
The Rotterdam Study, which found a 57% reduction in cardiovascular mortality associated with higher vitamin K2 intake, was a 7 to 10 year prospective cohort study. The cardiovascular protection associated with K2 is a long-term dietary and supplementation pattern, not an acute effect.
Immune Function: Seasonal Consistency and Year-Round Protection
Vitamin D3's role in immune function is well-established, but its immune benefits are most pronounced when serum 25(OH)D levels are maintained consistently above the threshold for immune cell activation (generally considered to be above 75 nmol/L).
The BMJ meta-analysis (2017) of 25 randomized controlled trials found that vitamin D supplementation reduced acute respiratory tract infection risk by 12% overall, with a 42% reduction in individuals who were deficient at baseline. This protective effect requires maintaining adequate vitamin D levels year-round, not just during winter months when deficiency is most common.
Supplementing consistently through spring and summer, when many Canadians assume sun exposure is sufficient, maintains the tissue-level vitamin D reserves that buffer against the rapid decline that occurs when UVB radiation becomes insufficient in autumn. A 300-softgel supply covering approximately 10 months of daily use bridges this gap seamlessly.
Vitamin D in Canada: Why Year-Round Supplementation Matters
Canada's geographic position creates a specific and well-documented vitamin D challenge. The angle of the sun relative to Canada's latitude means that UVB radiation (the wavelength required for cutaneous vitamin D synthesis) is insufficient for meaningful skin synthesis for approximately 4 to 5 months per year in most of the country, and longer in northern regions.
The Canadian Vitamin D Reality
- October to March: UVB radiation is insufficient for vitamin D synthesis across virtually all of Canada; supplementation is the only reliable source
- April and September: UVB is marginal; synthesis is possible but unreliable depending on cloud cover, time of day, and skin exposure
- May to August: UVB is sufficient for synthesis, but only with adequate skin exposure at midday, without sunscreen, for 15 to 30 minutes depending on skin tone
In practice, most Canadians do not achieve sufficient sun exposure even in summer months due to indoor work, sunscreen use, clothing, and darker skin pigmentation. Health Canada recommends vitamin D supplementation for all Canadians, with particular emphasis on fall and winter months, but year-round supplementation is appropriate for most adults.
An estimated 32% of Canadians are vitamin D deficient (serum 25(OH)D below 50 nmol/L) and up to 70% have suboptimal levels during winter. These statistics reflect the inadequacy of relying on seasonal sun exposure alone.
Choosing the Right Supply Size: The Case for 300 Softgels
For a supplement designed for long-term daily use, supply size is a practical decision with direct implications for supplementation consistency and cost efficiency.
The Consistency Argument
The primary risk to long-term supplementation consistency is running out of supply. When a bottle runs out, there is typically a gap of days to weeks before a replacement is purchased and arrives. For fat-soluble vitamins that require consistent daily intake to maintain tissue levels, these gaps are not trivial. Each interruption in supplementation begins the process of tissue level decline, requiring additional weeks of consistent intake to restore optimal levels.
A 300-softgel supply at 1 softgel per day provides approximately 10 months of uninterrupted supplementation. This extended supply period:
- Eliminates the risk of running out during the critical winter months when vitamin D supplementation is most important
- Reduces the frequency of reordering, minimizing the risk of supply gaps
- Provides sufficient supply to cover the full duration of clinical trials demonstrating bone and cardiovascular benefits (most trials run 6 to 36 months)
- Reduces per-softgel cost compared to smaller supply sizes
Supply Duration Comparison
| Supply Size | Duration at 1/day | Reorders Per Year | Covers Full Winter Season? |
|---|---|---|---|
| 30 softgels | 1 month | 12 | No (partial) |
| 60 softgels | 2 months | 6 | No (partial) |
| 120 softgels | 4 months | 3 | Partially |
| 300 softgels | 10 months | 1 to 2 | Yes (full season plus buffer) |
What Is in Each Softgel
Medicinal ingredients per softgel:
- Vitamin D3 (Cholecalciferol): 1,000 IU (25 mcg)
- Vitamin K2 (Natto-derived Menaquinone-7, MK-7): 120 mcg
Non-medicinal ingredients:
- Organic non-GMO coconut oil (fat carrier for optimal fat-soluble vitamin absorption)
- Bovine gelatin (softgel capsule shell)
Free from: Gluten, soy, dairy
NPN: 80065905
Made in Canada in a GMP-certified facility
Ingredient Quality Notes
Vitamin D3 (Cholecalciferol): The form of vitamin D produced in human skin upon UVB exposure and the most bioavailable supplemental form. Cholecalciferol is significantly more effective at raising serum 25(OH)D levels than vitamin D2 (ergocalciferol), the plant-derived alternative. Research published in the American Journal of Clinical Nutrition (2011) found that vitamin D3 was approximately 87% more potent than D2 in raising serum 25(OH)D levels.
Vitamin K2 (Natto-derived MK-7): MK-7 derived from natto (fermented soybeans) is the gold standard for K2 supplementation, providing the same biologically active form used in the majority of human clinical trials. Natto-derived MK-7 is the natural form with the 72-hour half-life that enables once-daily dosing.
Organic non-GMO coconut oil: Provides the fat matrix for optimal fat-soluble vitamin absorption. Organic certification ensures the coconut oil is free from synthetic pesticides and herbicides. Non-GMO certification confirms no genetically modified organisms in the supply chain.
300 Softgels vs 120 Softgels: Full Comparison
| Feature | 300 Softgels | 120 Softgels |
|---|---|---|
| Supply duration (1/day) | ~10 months | ~4 months |
| Reorders per year | 1 to 2 | 3 |
| Covers full Canadian winter | Yes (with buffer) | Partially |
| Formula per softgel | Identical (1,000 IU D3 + 120 mcg MK-7) | Identical |
| Coconut oil carrier | Yes | Yes |
| NPN | 80065905 | 80065905 |
| GMP certified, made in Canada | Yes | Yes |
| Best for | Long-term daily users; value-conscious buyers; those who want uninterrupted supply | First-time users; those wanting to try before committing to larger supply |
Dosage Guidelines and Timing
Recommended Dose
Adults: 1 softgel once daily
Each softgel provides 1,000 IU (25 mcg) of vitamin D3 and 120 mcg of vitamin K2 MK-7. This dose is:
- Within Health Canada's tolerable upper intake level for vitamin D3 (4,000 IU daily for adults)
- Consistent with the dose range used in clinical trials demonstrating bone and immune benefits
- Consistent with the dose range used in clinical trials demonstrating K2 MK-7 bone and cardiovascular benefits (90 to 200 mcg daily)
Timing and Administration
- With a meal: Take with a meal containing dietary fat for optimal absorption. The coconut oil in the softgel provides a built-in fat carrier, but taking with food further enhances absorption and tolerability
- Same time daily: Consistency in timing supports habit formation and ensures uninterrupted daily supplementation
- Morning or evening: No strong clinical evidence favoring a specific time of day; choose the meal time that best supports your daily routine
- Year-round: Daily supplementation year-round is appropriate for most Canadians given the limited UVB availability for 4 to 5 months per year and the suboptimal sun exposure patterns of most adults even in summer
Monitoring
Consider testing serum 25(OH)D levels before beginning supplementation and after 3 months of consistent daily use to confirm that levels have reached the optimal range (75 to 125 nmol/L). Annual testing thereafter helps confirm that maintenance dosing is adequate.
Safety Profile and Contraindications
Vitamin D3 Safety at 1,000 IU Daily
- 1,000 IU daily is well within Health Canada's tolerable upper intake level of 4,000 IU for adults
- Vitamin D toxicity (hypervitaminosis D) requires sustained intake well above 10,000 IU daily and is not a concern at 1,000 IU
- Well-tolerated in clinical trials at this dose across diverse populations
Vitamin K2 MK-7 Safety at 120 mcg Daily
- No established tolerable upper intake level; no toxicity observed at supplemental doses in clinical trials
- 120 mcg daily is within the range used safely in 3-year clinical trials
- Unlike vitamin K1, MK-7 at supplemental doses has minimal effect on blood clotting parameters in healthy individuals
Contraindications and Precautions
- Anticoagulant medications (warfarin): Vitamin K2 can affect warfarin activity; consult a healthcare practitioner before use. This is the primary contraindication for K2 supplementation.
- Hypercalcemia: Vitamin D3 increases calcium absorption; contraindicated in individuals with elevated blood calcium
- Granulomatous diseases: Conditions such as sarcoidosis can cause excessive vitamin D activation; consult healthcare provider
- Kidney disease: Impaired vitamin D metabolism; consult healthcare provider
- Pregnancy: Vitamin D supplementation is generally recommended during pregnancy; consult healthcare provider for appropriate dose
Frequently Asked Questions
How long should I take vitamin D3 and K2?
Vitamin D3 and K2 are most beneficial when taken consistently long-term. The clinical evidence for bone health benefits comes from trials of 1 to 3 years duration, with progressive improvements observed over time. For cardiovascular protection, the Rotterdam Study followed participants for 7 to 10 years. For most Canadians, year-round daily supplementation is appropriate given the limited UVB availability for 4 to 5 months per year and the suboptimal sun exposure patterns of most adults even in summer months.
Why does this formula use coconut oil?
Vitamin D3 and K2 are fat-soluble vitamins that require dietary fat for absorption. The organic non-GMO coconut oil within each softgel provides a built-in fat carrier that ensures consistent absorption regardless of the fat content of the meal consumed alongside it. Coconut oil's medium-chain triglycerides (MCTs) are absorbed rapidly and may enhance the absorption kinetics of co-administered fat-soluble compounds. This is a deliberate formulation choice that addresses the primary variable affecting fat-soluble vitamin absorption.
Is 1,000 IU of vitamin D3 enough?
For most adults supplementing to maintain adequate levels (above 75 nmol/L), 1,000 IU daily is an appropriate maintenance dose. Individuals who are severely deficient may require higher doses under healthcare provider supervision to correct deficiency more rapidly, after which 1,000 IU daily is appropriate for maintenance. Health Canada's tolerable upper intake level is 4,000 IU daily, so 1,000 IU provides a wide safety margin. Testing serum 25(OH)D levels is the most reliable way to confirm that your dose is adequate for your individual needs.
Why is MK-7 better than MK-4 for daily supplementation?
MK-7 has a plasma half-life of approximately 72 hours, compared to 1 to 2 hours for MK-4. This means a single daily dose of MK-7 maintains stable, sustained blood and tissue levels throughout the 24-hour dosing interval, providing continuous activation of osteocalcin and Matrix Gla Protein. MK-4 requires much higher doses taken multiple times daily to achieve comparable tissue saturation. MK-7 at 120 mcg once daily is clinically equivalent to MK-4 at doses 10 to 100 times higher, making MK-7 the practical choice for once-daily supplementation.
Do I need vitamin D3 supplements in summer in Canada?
For most Canadians, yes. While UVB radiation is sufficient for vitamin D synthesis in summer months, most adults do not achieve adequate skin exposure due to indoor work, sunscreen use, clothing, and skin pigmentation. Research shows that even in summer, many Canadians do not maintain optimal vitamin D levels without supplementation. Year-round daily supplementation is the most reliable strategy for maintaining consistent serum 25(OH)D levels above the optimal threshold throughout the year.
How many softgels are in the 300-softgel bottle and how long does it last?
The 300-softgel bottle provides approximately 10 months of supply at the recommended dose of 1 softgel per day. This extended supply period is designed to support uninterrupted long-term daily supplementation, covering the full Canadian winter season (October through March) plus an additional 4 to 5 months, with minimal reordering required.
Is this product suitable for vegetarians?
This product uses bovine gelatin for the softgel capsule shell and is therefore not suitable for vegetarians or vegans. Individuals seeking a plant-based alternative should consider the vegan D3+K2 capsule formula, which uses a hypromellose (plant-based) capsule with vitamin D3 from lichens and vitamin K2 MK-7 from natto.
Conclusion
Vitamin D3 and K2 MK-7 are fat-soluble vitamins whose benefits are built through consistent daily supplementation over months and years, not days and weeks. The clinical evidence for bone mineral density improvement, arterial stiffness reduction, and immune protection all comes from trials of 1 to 3 years duration, with progressive improvements observed at each time point. This is not a supplement to take occasionally. It is a supplement to take every day, without interruption, for the long term.
The 300-softgel format supports this long-term strategy by providing approximately 10 months of uninterrupted supply, eliminating the risk of running out during the critical winter months, and reducing the per-softgel cost of consistent daily supplementation. The coconut oil softgel format ensures optimal fat-soluble vitamin absorption regardless of meal composition. The 1,000 IU D3 and 120 mcg MK-7 per softgel formula is consistent with the doses used in clinical trials demonstrating meaningful bone and cardiovascular benefits.
For optimal results:
- Take 1 softgel daily with a meal, consistently, year-round
- Allow 2 to 3 months for serum 25(OH)D levels to reach their new steady state
- Consider testing serum 25(OH)D levels at baseline and after 3 months to confirm adequacy
- Continue supplementation year-round, including summer months, for consistent tissue-level maintenance
- Consult a healthcare practitioner if taking anticoagulant medications
Long-term daily vitamin D3 + K2 supplementation: Vitamin D3 + K2 300 Softgels — 1,000 IU D3 (cholecalciferol) + 120 mcg K2 (natto-derived MK-7) per softgel, organic non-GMO coconut oil carrier, approximately 10-month supply, gluten-free, soy-free, dairy-free, non-GMO, GMP certified, made in Canada, NPN 80065905.
References
1. Knapen MH, et al. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporosis International. 2013;24(9):2499-2507.
2. Knapen MH, et al. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. Thrombosis and Haemostasis. 2015;113(5):1135-1144.
3. Geleijnse JM, et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. Journal of Nutrition. 2004;134(11):3100-3105.
4. Martineau AR, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis. BMJ. 2017;356:i6583.
5. Tripkovic L, et al. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. American Journal of Clinical Nutrition. 2012;95(6):1357-1364.
6. Dawson-Hughes B, et al. Effect of vitamin D supplementation on serum 25-hydroxyvitamin D concentrations in healthy adults. American Journal of Clinical Nutrition. 2008;87(6):1952-1958.
7. Niramitmahapanya S, et al. Type of dietary fat is associated with the 25-hydroxyvitamin D3 increment in response to vitamin D supplementation. Journal of Clinical Endocrinology and Metabolism. 2011;96(10):3170-3174.